Correlation Between Polarityte and Pasithea Therapeutics
Can any of the company-specific risk be diversified away by investing in both Polarityte and Pasithea Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Polarityte and Pasithea Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Polarityte and Pasithea Therapeutics Corp, you can compare the effects of market volatilities on Polarityte and Pasithea Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Polarityte with a short position of Pasithea Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Polarityte and Pasithea Therapeutics.
Diversification Opportunities for Polarityte and Pasithea Therapeutics
0.83 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Polarityte and Pasithea is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Polarityte and Pasithea Therapeutics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pasithea Therapeutics and Polarityte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Polarityte are associated (or correlated) with Pasithea Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pasithea Therapeutics has no effect on the direction of Polarityte i.e., Polarityte and Pasithea Therapeutics go up and down completely randomly.
Pair Corralation between Polarityte and Pasithea Therapeutics
Considering the 90-day investment horizon Polarityte is expected to under-perform the Pasithea Therapeutics. In addition to that, Polarityte is 1.68 times more volatile than Pasithea Therapeutics Corp. It trades about -0.11 of its total potential returns per unit of risk. Pasithea Therapeutics Corp is currently generating about -0.02 per unit of volatility. If you would invest 1,370 in Pasithea Therapeutics Corp on October 11, 2024 and sell it today you would lose (1,090) from holding Pasithea Therapeutics Corp or give up 79.56% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 25.91% |
Values | Daily Returns |
Polarityte vs. Pasithea Therapeutics Corp
Performance |
Timeline |
Polarityte |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Pasithea Therapeutics |
Polarityte and Pasithea Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Polarityte and Pasithea Therapeutics
The main advantage of trading using opposite Polarityte and Pasithea Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Polarityte position performs unexpectedly, Pasithea Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pasithea Therapeutics will offset losses from the drop in Pasithea Therapeutics' long position.The idea behind Polarityte and Pasithea Therapeutics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Pasithea Therapeutics vs. Nutriband Warrant | Pasithea Therapeutics vs. MediciNova | Pasithea Therapeutics vs. Virax Biolabs Group | Pasithea Therapeutics vs. Revelation Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |